Document Detail


Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. II. Specific issues.
MedLine Citation:
PMID:  4037245     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Quality collaborative clinical trials cannot be run without the complete commitment of every investigator. The clinician must provide quality data and must submit the data on time. The statistical office and protocol coordinator are responsible for maintaining confidentiality and for keeping a watchful eye on the overall conduct of the study. Safety monitoring of experimental drugs or drug combinations is a central responsibility, since individual investigators generally only see the statistical reports on the study, rather than the raw data. It is critical that interim statistical reports be interpreted correctly so as not to affect accrual adversely. A separate issue discussed in this article is the answering of negative questions. Can therapy be reduced and still obtain equal efficacy? Such studies are based on sound ethical considerations, but they are hazardous since they could lead to serious worsening in cure rates.
Authors:
J J Shuster; J P Krischer; J M Boyett
Related Documents :
15860765 - Increasing the degrees of freedom in existing group randomized trials: the df* approach.
2697015 - Ensuring data quality in a multicenter clinical trial: remote site data entry, central ...
3060315 - Statistical properties of randomization in clinical trials.
17591655 - Pharmacological models in healthy volunteers: their use in the clinical development of ...
18499695 - Em-random forest and new measures of variable importance for multi-locus quantitative t...
23846745 - Sicop: identifying significant co-interaction patterns.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of pediatric hematology/oncology     Volume:  7     ISSN:  0192-8562     ISO Abbreviation:  Am J Pediatr Hematol Oncol     Publication Date:  1985  
Date Detail:
Created Date:  1985-10-15     Completed Date:  1985-10-15     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7908071     Medline TA:  Am J Pediatr Hematol Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  64-70     Citation Subset:  E; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / therapeutic use
Biometry
Clinical Trials as Topic / methods*
Confidentiality
Drug Evaluation
Ethics, Medical*
Humans
Information Dissemination
Neoplasms / drug therapy,  therapy*
Probability
Research Design
Research Subjects
Grant Support
ID/Acronym/Agency:
U-10 CA 29139-03/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Ethical issues in cooperative cancer therapy trials from a statistical viewpoint. I. A general overv...
Next Document:  Transient granulocyte maturation arrest: discovery by flow cytometry of a variant form of agranulocy...